Website stats for Akdae - akdae.de
Arzneimittelkommission der deutschen rzteschaftWissenschaftlicher Fachausschuss der Bundesrztekammer
It has a alexa rank of #1,237,710 in the world. It is a domain having .de extension. It is estimated worth of $ 960.00 and have a daily income of around $ 4.00. As no active threats were reported recently, akdae.de is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 708 |
| Daily Pageviews: | 1,416 |
Estimated Valuation
| Income Per Day: | $ 4.00 |
| Estimated Worth: | $ 960.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 1,237,710 |
| PageSpeed Score: | 68 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
185.236.252.151
Hosted Country:
DE
Location Latitude:
51.2217Location Longitude:
6.77616Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | No Data |
| Referral Traffic: | No Data |
| Search Traffic: | No Data |
| Social Traffic: | No Data |
| Mail Traffic: | No Data |
| Display Traffic: | No Data |
Search Engine Results For akdae.de
Arzneimittelkommission der deutschen Ärzteschaft
Als Ziel einer Behandlung der rheumatoiden Arthritis (RA) wird die Remission oder zumindest – insbesondere bei länger bestehender Erkrankung – eine geringe Krankheitsaktivität...
Drug Commission of the German Medical Association
The Drug Commission of the German Medical Association (DCGMA) is the scientific expert committee for drug-related matters of the German Medical Association.
akdae.de Competitive Analysis, Marketing Mix and Traffic ...
akdae.de Competitive Analysis, Marketing Mix and Traffic . vs. gelbe-liste.de arznei-telegramm.de der-arzneimittelbrief.de bfarm.de. Overview. Find, Reach, and Convert Your...
Alexander Kekulé - Wikipedia
Alexander S. Kekulé (born November 7, 1958, as Alexander Urchs in Munich) is a German doctor and biochemist.Since 1999 he has held the chair for Medical Microbiology and...
akdae.de | SEO Bewertung | Seobility.net
SEO Bewertung von akdae.de. Onpage Analyse, Seitenstruktur, Seitenqualität, Links und konkurrierende Webseiten.
akdae.de | akdae.de est sécuritaire ? - Vérifier si c'est ...
Vérifiez akdae.de site est une arnaque ou un site Web sécurisé. akdae.de détecter si elle est une arnaque, frauduleuse ou est infectés par des malwares, le …
akdae.de | ¿es akdae.de seguro? - Comprobar si es una estafa
Comprobar si akdae.de es un sitio web de estafa o un sitio web seguro. Detecte si akdae.de es una estafa, fraudulento o esta infectado con malware, phishing, fraude y si tiene...
akdae.de | ist akdae.de sicher? - Prüfen Sie, ob ein ...
Überprüfen Sie, ob akdae.de ein Betrug Website oder eine sichere Website ist. Ermitteln Sie, ob akdae.de ist ein Betrug, betrügerische oder infiziert mit Malware, Phishing,...
Martina Pötschke-Langer - Wikipedia
This article is an orphan, as no other articles link to it.Please introduce links to this page from ; try the Find link tool for suggestions. (August 2019)
Medicines in Germany - deutschland.de
The Drug Commission of the German Medical Profession (Arzneimittelkommission der deutschen Ärzteschaft, AkdÄ) is an expert committee of the Federal Medical Association...
Adverse reactions to anticoagulants and to antiplatelet ...
[email protected]; PMID: 16149013 DOI: 10.1055/s-2005-916670 Abstract According to their code of professional conduct, German physicians are obliged to report suspected...
Effectiveness and safety of dipeptidyl peptidase 4 ...
Affiliations 1 Drug Commission of the German Medical Association, Berlin, Germany. [email protected].; 2 NIHR School for Primary Care Research, Manchester Academic Health...
akdae.de - SiteGur
Akdae.de receives about 0 monthly visitors. This domain is ranked 0. Estimated worth of this site is $0.
akdae.de | SEO Bewertung | Seobility.net
SEO Bewertung von akdae.de. Onpage Analyse, Seitenstruktur, Seitenqualität, Links und konkurrierende Webseiten.
Biosimilars in Germany: guidance of the Drug Commission of ...
Abstract: Biosimilars have been available in Europe for more than 10 years, but their adoption in Germany has not been very successful. As their pharmaceutical quality, efficacy...
Management Board members | European Medicines Agency
This page lists the current members of the European Medicines Agency's Management Board.. It lists each member's contact details, as well as his or her declaration of interests...
European Medicines Agency
EMA receives applications for two COVID-19 vaccines. BioNTech/Pfizer and Moderna have submitted applications for their Covid-19 vaccines. The Agency’s human medicines committee...
Pure Red-Cell Aplasia and Epoetin Therapy | NEJM
Background Between 1988 and 1998, antibody-associated pure red-cell aplasia was reported in three patients who had undergone treatment with recombinant …
The financing of drug trials by pharmaceutical companies ...
1. Dtsch Arztebl Int. 2010 Apr;107(16):279-85. doi: 10.3238/arztebl.2010.0279. Epub 2010 Apr 23. The financing of drug trials by pharmaceutical companies and its consequences.
Healthcare resource use and costs of multiple sclerosis ...
Mar 27, 2017 · Multiple sclerosis (MS) is a chronic and progressive autoimmune disease of the central nervous system. MS patients suffer from diverse symptoms, whereas gait...
For sale: Stem cell enhancers | The Scientist Magazine®
May 14, 2007 · A California company is marketing the latest in dietary supplements, an extract from algae they claim will boost the number of circulating stem cells, easing...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | 1 |
| H3 Headings: | 35 | H4 Headings: | 11 |
| H5 Headings: | 12 | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 44 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| der AkdÄ | 20 | 1.476 % | No |
| Drug Safety | 18 | 1.328 % | No |
| Safety Mail | 18 | 1.328 % | No |
| in der | 14 | 1.033 % | No |
| SGB V | 9 | 0.664 % | No |
| Nutzenbewertung § | 9 | 0.664 % | No |
| RoteHandBrief zu | 9 | 0.664 % | No |
| frühe Nutzenbewertung | 8 | 0.59 % | No |
| § 35a | 8 | 0.59 % | No |
| 35a SGB | 8 | 0.59 % | No |
| AkdÄ zu | 7 | 0.517 % | No |
| – frühe | 6 | 0.443 % | No |
| Mehr Informationen | 6 | 0.443 % | No |
| V Volltext | 6 | 0.443 % | No |
| Neue Arzneimittel | 5 | 0.369 % | No |
| Fortbildungsveranstaltung der | 5 | 0.369 % | No |
| Oktober 2019 | 4 | 0.295 % | No |
| Stellungnahme der | 4 | 0.295 % | No |
| AkdÄ in | 4 | 0.295 % | No |
| Terminhinweis Fortbildungsveranstaltung | 4 | 0.295 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| § 35a SGB V | 8 | 0.59 % | No |
| Nutzenbewertung § 35a SGB | 7 | 0.517 % | No |
| 35a SGB V Volltext | 6 | 0.443 % | No |
| frühe Nutzenbewertung § 35a | 6 | 0.443 % | No |
| – frühe Nutzenbewertung § | 6 | 0.443 % | No |
| Arzneiverordnung in der Praxis | 4 | 0.295 % | No |
| Stellungnahme der AkdÄ zu | 4 | 0.295 % | No |
| Terminhinweis Fortbildungsveranstaltung der AkdÄ | 4 | 0.295 % | No |
| Fortbildungsveranstaltung der AkdÄ in | 4 | 0.295 % | No |
| in der Praxis AVP | 3 | 0.221 % | No |
| Volltext 02102019 Drug Safety | 2 | 0.148 % | No |
| 02102019 Drug Safety Mail | 2 | 0.148 % | No |
| des studentischen Netzwerks gegen | 2 | 0.148 % | No |
| studentischen Netzwerks gegen Interessenkonflikte | 2 | 0.148 % | No |
| von Fach und Gebrauchsinformationen | 2 | 0.148 % | No |
| gegen Interessenkonflikte in der | 2 | 0.148 % | No |
| 16 Oktober 2019 Volltext | 2 | 0.148 % | No |
| atopischen Dermatitis mit Dupilumab | 2 | 0.148 % | No |
| Änderung von Fach und | 2 | 0.148 % | No |
| Netzwerks gegen Interessenkonflikte in | 2 | 0.148 % | No |
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Server: nginx
Date: Wed, 20 Nov 2019 16:38:01 GMT
Content-Type: text/html; charset=utf-8
Content-Length: 10689
Connection: keep-alive
Last-Modified: Wed, 20 Nov 2019 13:06:02 GMT
ETag: "db77-597c6d7c09731-gzip"
Accept-Ranges: bytes
Vary: Accept-Encoding
Content-Encoding: gzip
Strict-Transport-Security: max-age=63072000; includeSubDomains; preload
X-Frame-Options: SAMEORIGIN
X-XSS-Protection: 1; mode=block
Domain Information
| Domain Registrar: |
DENIC eG
|
|---|---|
| Last Modified: | 2018-06-07 6 years 5 months 2 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| nsa8.schlundtech.de | |
62.116.159.18 | Germany |
| nsb8.schlundtech.de | |
217.160.113.58 | Germany |
| nsc8.schlundtech.de | |
89.146.248.28 | Germany |
| nsd8.schlundtech.de | |
74.208.254.28 | Germany |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| akdae.de | A | 86365 |
IP: 185.236.252.151 |
| akdae.de | NS | 86400 |
Target: nsb8.schlundtech.de |
| akdae.de | NS | 86400 |
Target: nsa8.schlundtech.de |
| akdae.de | NS | 86400 |
Target: nsc8.schlundtech.de |
| akdae.de | NS | 86400 |
Target: nsd8.schlundtech.de |
| akdae.de | SOA | 86400 |
MNAME: nsa8.schlundtech.de RNAME: webmaster.akdae.de Serial: 2018060700 Refresh: 43200 Retry: 7200 Expire: 1209600 |
| akdae.de | MX | 86400 |
Priority: 100 Target: mail.akdae.de |
| akdae.de | MX | 86400 |
Priority: 10 Target: mail01.akdae.de |
Full WHOIS Lookup
%
% Terms and Conditions of
Use
%
% The above data may only be used within the scope of
technical or
% administrative necessities of Internet operation or
to remedy legal
% problems.
% The use for other purposes, in
particular for advertising, is not permitted.
%
% The DENIC
whois service on port 43 doesn't disclose any information
concerning
% the domain holder, general request and abuse
contact.
% This information can be obtained through use of our
web-based whois service
% available at the DENIC website:
%
http://www.denic.de/en/domains/whois-service/web-whois.html
%
%
Domain: akdae.de
Nserver:
nsa8.schlundtech.de
Nserver: nsb8.schlundtech.de
Nserver:
nsc8.schlundtech.de
Nserver: nsd8.schlundtech.de
Status:
connect
Changed: 2018-06-07T11:18:34+02:00
Similarly Ranked Websites
ARTDOXA - Community for Contemporary Art
ARTDOXA - Community for Contemporary Art, artists and audience
1,237,733 
$ 960.00
BusinessAcademy | Poslovna Akademija
Business Academy, jednogodisnje školovanje iz oblasti menadžmenta, preduzetništva, marketinga, poslovne administracije i Cambridge International Diploma in Business.
1,237,759 $ 960.00